Serotonin deficiency in infancy as a cause of a mental defect in experimental phenylketonuria.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use*; D000818:Animals; D000831:Animals, Newborn; D002746:Chlorpromazine; D004597:Electroshock; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008607:Intellectual Disability / Q000209:etiology / Q000517:prevention & control*; D007858:Learning; D008297:Male; D008550:Melatonin / Q000627:therapeutic use; D051379:Mice; D009489:Neurosecretion; D010649:Phenylalanine / Q000494:pharmacology; D010661:Phenylketonurias / Q000209:etiology*; D010667:Phenylpyruvic Acids; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D014363:Tryptamines / Q000494:pharmacology*; D014443:Tyrosine / Q000494:pharmacology; D014556:Urine
D010667:Phenylpyruvic Acids; D014363:Tryptamines; D012701:Serotonin; D014443:Tyrosine; D010649:Phenylalanine; D012110:Reserpine; D006916:5-Hydroxytryptophan; D008550:Melatonin; D002746:Chlorpromazine